I was at Voyager's presentation yesterday at the MJFF Therapeutics Research conference. It was quite impressive. On the other hand, the stock got wacked today when Sanofi dropped their option to their US marketing rights (which were maintained by Voyager). Seems possible, yet still very suprising that a major big pharma would walk away from potentially ground breaking drug and technology. I guess we'll know more as future results come in........


There were a number of other very interesting studies, including more evidence of the involvement with the gut; evidence of immune response and T cell involvement (although not autoimmune); and a great debate on whether or not PD is a prion-like disease (the researcher showed why he believes it is NOT a prion-like disease).